Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Blocking IL-17a can improve age-related smell loss in mice.

Virus infection risk is linked to heat tolerance and size, but decreases with high humidity and mutation rate.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Macrophages help maintain mammary stem cells and balance through specific signaling.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

PRP treatment may help with alopecia areata, especially in newer cases.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Exosomes can help promote hair growth and may treat hair loss.

Fractional lasers effectively treat alopecia areata, especially when combined with minoxidil or cortisol.

Herbal medicine might be a good alternative for treating hair loss.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.